Dot Compliance, a leading provider of eQMS compliance solutions for the life sciences sector, has introduced an industry-first, ready-to-use AI-Based electronic Quality Management System for life sciences, powered by an embedded generative and predictive artificial intelligence.
Share: email Subscribe
Weekly Top Stories Tue 11 Apr 2023
We have 30 articles this week. #Clearday and #Viveon Health Merge to Create Longevity Care Company. #Amazon’s acquisition of iRobot under investigation in the UK. #Select Medical Signs Agreement to Acquire Vibra Hospital of Richmond. #Indian RPM startup Dozee gets $6M to kickstart global expansion. #Reproductive health app Clue scores €7 million. #AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery #Biostage Raises $6M to Advance Clinical Trials. #Handheld X-ray device maker OXOS Medical scores $23M. #Aetna partners with gastrointestinal care company Oshi Health #Penumbra, Veterans Health Administration partner to create VR-based therapeutics.
Editor's Choice
1. 
Dot Compliance Launches First AI-Based ChatGPT Powered eQMS for Life Sciences
2. 
Cognizant to Integrate TriZetto with Microsoft Cloud for Healthcare
3. 
PsychoGenics Launches AI Platform to Revolutionize Drug Discovery
4. 
Qure.ai Joins Medtronic India’s Stroke Care Initiative
Top 10 M&A Transactions
5. 
Clearday and Viveon Health Merge to Create Longevity Care Company
6. 
Amazon’s Acquisition of Irobot Under Investigation in the Uk
7. 
Select Medical Signs Agreement to Acquire Vibra Hospital of Richmond
8. 
Indian RPM Startup Dozee Gets $6M to Kickstart Global Expansion
9. 
Reproductive Health App Clue Scores €7 Million
10. 
AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery
11. 
Boston Scientific Completes $615M Acquisition of Apollo Endosurgery
12. 
Nova Research Laboratories, LLC Announces Acquisition of CiPA Lab
13. 
SK Capital Completes Acquisition of Apotex, a Global Leader in Affordable Pharmaceuticals
14. 
Sumitomo Pharma Subsidiary Companies in the U.S., Including Sumitovant and Its Wholly Owned Subsidiaries, to Combine and Form Sumitomo Pharma America
Top 5 Venture Funding
15. 
Biostage Raises $6M to Advance Clinical Trials
16. 
Handheld X-ray Device Maker OXOS Medical Scores $23M
17. 
HeartFlow Raises $215M for AI-Powered Cardiac Test
18. 
Better Therapeutics Announces $6.5M Private Placement
19. 
Q1 2023 Digital Health Funding Reaches $3.4B Across 132 Deals
Top 5 Partnerships Announcements
20. 
Aetna Partners with Gastrointestinal Care Company Oshi Health
21. 
Penumbra, Veterans Health Administration Partner to Create VR-based Therapeutics
22. 
Intermountain Health Expands Relationship with Kyruus for Rebranded Digital Patient Experience
23. 
Alcohol Recovery Companies Monument, Tempest Shared Health Data with Advertisers
24. 
Mark Cuban Cost Plus Drug Company Partners with Latino-focused Care Startup
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us